Trial of Tirzepatide for the Treatment of Cannabis Use Disorder

NCT07468552 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

NIH

Sponsor class

Conditions

Cannabis Use Disorder

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)